Latest filing published 05 May 2022 for ExpreS2ion Biotech Holding AB (EXPRS2), €7,598.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Allan Rosetzsky: trading record in brief
This profile gathers the share dealings of Allan Rosetzsky across 3 companies, led by ExpreS2ion Biotech Holding AB, ExpreS2ion Biotech Holding AB (EXPRS2) and Expres2ion Biotech AB. Over a trading history stretching from 21 August 2017 to 5 May 2022, the count stands at 15 filings.
Both buying and selling appear: 6 purchases worth €186k, against 4 sales worth €193k. The net balance comes to €7,239 on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. So far in 2022, the count stands at 1 purchase and no sales.
Half of the purchases are above €23k and half below. No cluster: in 5 purchases, no other insider of the company bought within 30 days.
The record was last updated on 5 May 2022 with an open-market purchase (€7,598) in ExpreS2ion Biotech Holding AB (EXPRS2). Filings reach the Finansinspektionen feed a median of 4 days after the trade. The legal deadline for notifying a trade is three business days (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Allan Rosetzsky
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 6,375 shares@ SEK 12.5020.1% of flowBTA (betald tecknad aktie)ISIN SE0017780687FI:csv-4f90a634914d39319eadCanonical exit: 3 Aug 2022 (T+90)
- 3,700 shares@ SEK 25.0024.0% of flowAktieISIN SE0008348262FI:csv-1512993e28419b8e8478
- 11,100 shares0WarrantISIN SE0014958336FI:csv-7faec677abccc6e72f95
- 34,000 shares0TeckningsrättISIN SE0014957957FI:csv-8920d9ee14e95719e644
- 27,000 shares@ SEK 18.094414.5% of flowAktieISIN SE0008348262FI:csv-603a05ae656079509b23
- 7,544 shares@ SEK 29.00100.0% of flowAktieISIN SE0008348262FI:csv-0b2e5b4a6309e3f1a6c9
- 11,550 shares@ SEK 24.249257.1% of flowAktieISIN SE0008348262FI:csv-f3374d2c4ae644334ce5
- 25,200 shares@ SEK 6.9635.9% of flowWarrantISIN SE0008348262FI:csv-ae5b647aba07d46aa716
- 34,000 shares@ SEK 4.384.3% of flowAktieISIN SE0008348262FI:csv-e2ee95ee5cb6e3acbda5Canonical exit: 12 Dec 2019 (T+90)
- 67,727 shares@ SEK 4.90459.9% of flowAktieISIN SE0008348262FI:csv-8bc68a1bfb3eb2aee3d6Canonical exit: 11 Mar 2019 (T+90)
- 900 shares@ SEK 5.000.1% of flowAktieISIN SE0008348262FI:csv-b4b131fd66f737ae85b3Canonical exit: 13 Mar 2019 (T+90)
- 69,646 shares@ SEK 13.702630.4% of flowISIN SE0008348262FI:csv-2e7ecbd80555a36608e5
- 71,638 shares@ SEK 4.5010.4% of flowISIN SE0008348262FI:csv-29ac426e522e9dc5e7daCanonical exit: 19 Nov 2017 (T+90)
- 123,750 shares@ SEK 8.0030.3% of flowISIN SE0008348262FI:csv-a7cf3ab84f8421e06942Canonical exit: 30 May 2018 (T+90)
14 of 14 declarations